Skip to content
Lucky Services Blog

Social Media Content Creators Fueling Unofficial Trade for Unapproved Slimming Drug

An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, risking penalties, legal action or prison.

Platform Reaction and Material Removal

Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for mixing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Within these groups, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious medical dangers”.

By

James Orr

A tech enthusiast and IT consultant with over 8 years of experience in digital solutions and cybersecurity.

Lucky Services Blog

Type to search articles.